A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone - Tomokiyo, K; Nakatomi, Y; Araki, T (Vox Sang, 2003)
et al.